Microbiotica
PrivateLast Round
Series C
Oct 16, 2026
Est. Valuation
$195.93M
Total Funding Raised
$130.2M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Microbiotica operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Series C round in October 2026.
Microbiotica is a biotechnology company that develops live bacterial therapeutics and biomarkers based on microbiome science.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Microbiotica Comparables
Compare Microbiotica with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MRM Health | 85% | |
| MarvelBiome Inc. | 83% | |
| Shanghai Lishan Biopharmaceutical Co., Ltd. | 82% |
For institutional investors. Book with your work email.
Microbiotica Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Oct 16, 2026 | ||||
| Series B | Mar 7, 2022 | ||||
| Series A | Oct 24, 2018 | ||||
| Seed | Dec 15, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Microbiotica Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IP Group | Series C, Series A, Series B, Seed |
| British Business Bank | Series C |
| Flerie Invest | Series C, Series B |
| British Patient Capital | Series B |
| British Patient Capital | Series B |
| Cambridge Innovation Capital | Series C, Series A, Series B, Seed |
| Flerie AB | Series C, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 16, 2026
$48M round led by British Business Bank.
- Sep 12, 2026
Monthly visitors increased 34% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 26, 2026
Microbiotica presents encouraging Phase 1b MELODY-1 clinical data on MB097, its precision microbiome therapeutic for advanced melanoma, at the European Society for Medical Oncology (ESMO) Congress 2026 in Spain on Oct 26th '26.
- receives_financingOct 16, 2026
Microbiotica announces the first close of its $47.7M Series C financing in United Kingdom on Oct 16th '26, led by British Business Bank with participation from Tencent, IP Group, Cambridge Innovation Capital, Flerie Invest, Seventure Partners, and existing Series B investors to advance MB310 into Phase 2 development for ulcerative colitis.
For institutional investors. Book with your work email.
Microbiotica Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Microbiotica's valuation, stock price, and market status.
Is Microbiotica a public or private company?
Microbiotica is a private company.
What is the current stock price of Microbiotica?
Microbiotica is a private company, so its shares have no public market price. Caplight tracks Microbiotica's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Microbiotica worth (valuation)?
Microbiotica's valuation is estimated at $195.9M based on funding round data.
Can I buy Microbiotica stock?
Microbiotica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Microbiotica's last funding round?
Microbiotica's most recent funding round was Series C on October 16, 2026.
Who are the main investors in Microbiotica?
Key investors in Microbiotica include IP Group, British Business Bank, Flerie Invest, Cambridge Innovation Capital, Flerie AB.
Will Microbiotica IPO soon?
No public IPO plans have been announced for Microbiotica.
How can I track Microbiotica secondary market activity?
Caplight tracks bids, offers, and trades in Microbiotica's shares on secondary markets.